$2.32
7.20% yesterday
Nasdaq, Jun 13, 10:15 pm CET
ISIN
US45779A8466
Symbol
NSPR

InspireMD Inc Stock price

$2.32
-0.11 4.53% 1M
-0.63 21.36% 6M
-0.31 11.79% YTD
-0.28 10.77% 1Y
-5.93 71.88% 5Y
-1,645,216.43 100.00% 10Y
-437,497.68 100.00% 20Y
Nasdaq, Closing price Fri, Jun 13 2025
-0.18 7.20%
ISIN
US45779A8466
Symbol
NSPR
Sector

Key metrics

Market capitalization $71.07m
Enterprise Value $45.07m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 6.41
P/S ratio (TTM) P/S ratio 10.11
P/B ratio (TTM) P/B ratio 2.49
Revenue growth (TTM) Revenue growth 8.49%
Revenue (TTM) Revenue $7.03m
EBIT (operating result TTM) EBIT $-37.09m
Free Cash Flow (TTM) Free Cash Flow $-27.29m
Cash position $26.00m
EPS (TTM) EPS $-0.71
P/S forward 9.86
EV/Sales forward 6.25
Short interest 0.91%
Show more

Is InspireMD Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.

InspireMD Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a InspireMD Inc forecast:

2x Buy
100%

Analyst Opinions

2 Analysts have issued a InspireMD Inc forecast:

Buy
100%

Financial data from InspireMD Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
7.03 7.03
8% 8%
100%
- Direct Costs 5.53 5.53
16% 16%
79%
1.50 1.50
13% 13%
21%
- Selling and Administrative Expenses 24 24
40% 40%
341%
- Research and Development Expense - -
-
-
-37 -37
54% 54%
-523%
- Depreciation and Amortization 0.31 0.31
29% 29%
4%
EBIT (Operating Income) EBIT -37 -37
53% 53%
-528%
Net Profit -36 -36
59% 59%
-512%

In millions USD.

Don't miss a Thing! We will send you all news about InspireMD Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

InspireMD Inc Stock News

Neutral
GlobeNewsWire
one day ago
MIAMI, June 13, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced the company has received CE Mark approval under the European Medical Device Regulation (MDR) for the CGuard® Prime EPS.
Neutral
GlobeNewsWire
11 days ago
MIAMI, June 03, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced the appointment of Michael Lawless, an industry veteran, as Chief Financial Officer, effective on or prior to June 30, 2025 (the “Effective Date”). On the Effective Date, Mr.
Neutral
Seeking Alpha
about one month ago
InspireMD, Inc. (NASDAQ:NSPR ) Q1 2025 Earnings Conference Call May 9, 2025 8:30 AM ET Company Participants Webb Campbell – Gilmartin Group LLC Marvin Slosman – Chief Executive Officer Craig Shore – Chief Financial Officer Shane Gleason – Chief Commercial Officer Conference Call Participants Adam Maeder – Piper Sandler Frank Takkinen – Lake Street Capital Operator Good morning, and welcome to I...
More InspireMD Inc News

Company Profile

InspireMD, Inc. operates as a medical device company, which engages in the development and commercialization of the stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Tel Aviv, Israel.

Head office United States
CEO Marvin Slosman
Employees 86
Founded 2005
Website www.inspiremd.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today